Methadone

Pain Management

Methadone is used for the treatment of pain severe enough to require daily, around-the-clock, long-term opioid treatment. It is generally reserved for situations where alternative treatment options, such as non-opioid medications or immediate-release opioids, are ineffective or not tolerated.

Opioid Use Disorder

Methadone is a common component of medication-assisted treatment (MAT) for individuals addicted to opioid drugs, including heroin and prescription painkillers. When used for this purpose, it is typically administered through a certified treatment program. Its primary functions in addiction recovery include:

• Reducing or eliminating withdrawal symptoms.
• Decreasing the intense cravings for other opioids.
• Blocking the effects of other opioid drugs.

By stabilizing the brain chemistry, methadone allows individuals to focus on counseling and other recovery efforts without the physical distress of withdrawal.

How Methadone Works in the Body

Methadone is a long-acting opioid medication. It works by attaching to specific receptors in the brain and spinal cord known as opioid receptors. By binding to these sites, it alters the way the central nervous system perceives and responds to pain signals.

Treatment for Opioid Use Disorder

When used as part of a treatment program for addiction, methadone helps stabilize the body by mimicking some of the effects of other opioids without producing the same intense high. It works in several ways:

• Preventing Withdrawal: It provides enough stimulation to the brain's receptors to prevent the physical symptoms of withdrawal that occur when someone stops using shorter-acting opioids like heroin or oxycodone.
• Reducing Cravings: By keeping the receptors occupied, it helps decrease the physical urge to use other drugs.
• Blocking Effects: Because methadone stays attached to the receptors for a long time, it can block the euphoric effects of other opioids if they are taken.

Methadone is processed slowly by the body. This long-acting nature allows it to provide a steady effect over a long period, which helps prevent the cycle of highs and lows often experienced with other opioid drugs.

Common Side Effects

Many people experience mild side effects when taking methadone. These may include:

• Nausea or vomiting
• Constipation
• Dizziness or lightheadedness
• Drowsiness
• Increased sweating
• Dry mouth
• Headache
• Stomach pain
• Weight gain
• Difficulty falling asleep or staying asleep

Serious Side Effects

Contact a healthcare provider immediately or seek emergency medical care if you experience any of the following serious symptoms:

• Slow, shallow, or irregular breathing
• Chest pain or a fast, pounding heartbeat
• Extreme drowsiness or inability to wake up
• Feeling faint or lightheaded
• Seizures
• Confusion or hallucinations
• Severe muscle stiffness, twitching, or tremors
• Signs of an allergic reaction, such as a rash, hives, or swelling of the face, lips, tongue, or throat
• Changes in vision

Long-term use of methadone may also affect fertility in men and women or cause changes in menstrual periods and sexual desire.

Boxed Warnings

Methadone is associated with several serious risks that require close medical supervision. These include life-threatening respiratory depression, which is most likely to occur when starting treatment or after a dose increase. There is also a risk of serious heart rhythm changes, such as QT interval prolongation, which can be fatal.

Combining methadone with benzodiazepines, alcohol, or other central nervous system depressants can lead to severe sedation, respiratory failure, coma, and death. Additionally, accidental ingestion of even one dose can be fatal, particularly for children. Long-term use during pregnancy may result in neonatal opioid withdrawal syndrome, a condition that can be life-threatening for the infant if not recognized and treated.

Contraindications

This medication should not be used by individuals with certain medical conditions, including:

• Severe or acute bronchial asthma in an unmonitored setting or without resuscitative equipment.
• Known or suspected gastrointestinal obstruction, including paralytic ileus.
• Significant respiratory depression.
• Hypersensitivity to methadone.

Additional Precautions

Methadone has a long half-life, meaning it stays in the body for an extended period. This can lead to the drug accumulating in the system, which increases the risk of overdose if doses are taken too frequently. Healthcare providers often perform electrocardiogram (ECG) monitoring to check for heart rhythm issues and assess for signs of respiratory distress. Caution is also advised for individuals with a history of head injury, increased intracranial pressure, or certain abdominal conditions.

Pregnancy

Methadone is frequently used during pregnancy to treat opioid use disorder. Abruptly stopping opioid treatment during pregnancy can lead to serious complications for both the pregnant person and the developing fetus. However, long-term use of methadone during pregnancy may cause the baby to experience neonatal opioid withdrawal syndrome (NOWS) after birth. This condition is treatable but requires medical monitoring and care in a hospital setting.

If you are pregnant or planning to become pregnant, discuss the risks and benefits of methadone with your healthcare provider. They can help determine the most appropriate treatment plan for your health needs and the safety of the fetus.

Breastfeeding

Methadone passes into breast milk in small amounts. For many individuals on a stable dose of methadone, breastfeeding is often encouraged because it may help reduce the severity of withdrawal symptoms in the infant. However, it is essential to monitor the baby for signs of excessive sleepiness, difficulty breathing, or limpness.

Consult with a healthcare professional before breastfeeding while taking methadone. If you decide to stop taking methadone or stop breastfeeding, it should be done gradually under medical guidance to prevent withdrawal symptoms in the infant.

Oral Forms

Methadone is frequently prescribed as an oral medication. The available oral formats include:

• Tablets: Standard oral tablets intended to be swallowed whole.
• Dispersible Tablets: These tablets are designed to be dissolved in water or fruit juice before being swallowed. They are primarily used in supervised addiction treatment settings.
• Oral Solution: A liquid version of the medication.
• Oral Concentrate: A concentrated liquid that must be diluted with water or juice before administration.

Injectable Forms

Methadone is available as a solution for injection. It is typically administered by a healthcare provider through intravenous, intramuscular, or subcutaneous routes.

FDA Approval and Indications

Methadone was first approved by the FDA in 1947. It is currently indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment for which alternative treatment options are inadequate. It is also FDA-approved for the detoxification treatment and maintenance treatment of opioid addiction (opioid use disorder) in conjunction with appropriate social and medical services.

Boxed Warnings

The FDA requires a boxed warning for methadone due to several serious risks:

• Respiratory Depression: Fatal respiratory depression may occur, especially during the initiation of therapy or following a dose increase.
• QT Prolongation: Methadone has been associated with heart rhythm changes (QT interval prolongation) and serious arrhythmias.
• Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal overdose.
• Neonatal Opioid Withdrawal Syndrome: Prolonged use during pregnancy can lead to life-threatening withdrawal symptoms in the newborn.
• Interaction with Benzodiazepines: Concomitant use of opioids with benzodiazepines or other central nervous system depressants may result in profound sedation, respiratory depression, coma, and death.

Regulatory Controls and REMS

Methadone is classified as a Schedule II controlled substance under the Controlled Substances Act. For the treatment of opioid use disorder, federal law requires that methadone be dispensed only by certified Opioid Treatment Programs (OTPs). It is also part of the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which requires manufacturers to make training programs available to healthcare providers.

Safety Communications

The FDA has issued safety communications advising healthcare professionals not to withhold methadone from patients taking benzodiazepines or other CNS depressants. While the combination increases risks, the FDA notes that the dangers of untreated opioid addiction may be greater than the risks of using these medications together.

Symptoms of Methadone Withdrawal

If you stop taking methadone abruptly after your body has become accustomed to it, you may experience withdrawal symptoms. These symptoms can range from mild to severe and typically include:

• Anxiety, restlessness, or irritability
• Difficulty sleeping (insomnia)
• Muscle aches and joint pain
• Sweating, chills, or goosebumps
• Runny nose and watery eyes
• Nausea, vomiting, stomach cramps, or diarrhea
• Dilated pupils and yawning

Timeline and Management

Withdrawal symptoms usually begin within 24 to 72 hours after the last dose. Because methadone stays in the body longer than many other opioids, the withdrawal process may last longer, sometimes persisting for several days or weeks. To minimize these effects, healthcare providers typically use a tapering schedule, slowly lowering the dose over a period of time. You should never stop taking methadone or change your dose without consulting your doctor, as rapid withdrawal can be highly uncomfortable and may increase the risk of returning to other opioid use.